Back to search

Article

Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterations

2023-03-16

Abstract excerpt

<title>Abstract</title> <p>Identifying patients with low tumor mutation burden (TMB) that are likely to respond to cancer immunotherapy is an important, yet highly challenging clinical need. Using 3,139 patients across 17 different cancer types, we comprehensively studied the ability of two common copy number alteration (CNA) scores – the tumor aneuploidy score (AS) and the fraction of genome encompassed by copy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ddb3d799-f302-5b37-a990-533119c9f528
DOI
10.21203/rs.3.rs-2644875/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing cancer immunotherapy response prediction by tumor aneuploidy score and fraction of copy number alterationsDOI 10.21203/rs.3.rs-2644875/v1
Select a neighboring publication to make it the new centre.